Literature DB >> 12173150

Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy.

Elvis Peter1, Faris Bakri, Donna M Ball, Richard T Cheney, Brahm H Segal.   

Abstract

We report a case of invasive pulmonary filamentous fungal infection in a patient with chronic obstructive pulmonary disease who was treated with a conventional dose of inhaled fluticasone in the absence of other causes of immunosuppression. This case demonstrates the potential risk for opportunistic fungal infections in patients treated with high-potency lipophilic inhaled corticosteroids.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12173150     DOI： 10.1086/341971

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease.

Authors:  J Morgan Knight; Pijus Mandal; Pietro Morlacchi; Garbo Mak; Evan Li; Matthew Madison; Cameron Landers; Brandon Saxton; Ed Felix; Brian Gilbert; Joel Sederstrom; Atul Varadhachary; Melissa M Singh; Dev Chatterjee; David B Corry; John S McMurray
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

2.  Immunity status of invasive pulmonary aspergillosis patients with structural lung diseases in Chinese adults.

Authors:  Shuo Liang; Rong Jiang; Hai-Wen Lu; Bei Mao; Man-Hui Li; Cheng-Wei Li; Shu-Yi Gu; Jiu-Wu Bai; Jin-Fu Xu
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 3.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease.

Authors:  Florence Ader
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

5.  TLR4 recognizes Pseudallescheria boydii conidia and purified rhamnomannans.

Authors:  Rodrigo T Figueiredo; Patrícia L Fernandez; Fabianno F Dutra; Yissett González; Lívia Cristina Lopes; Vera Carolina B Bittencourt; Guilherme L Sassaki; Eliana Barreto-Bergter; Marcelo T Bozza
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

6.  Assessment of the significance of respiratory culture of Aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria.

Authors:  R C Barton; R P Hobson; H McLoughlin; A Morris; B Datta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-01       Impact factor: 3.267

Review 7.  Identification and management of invasive mycoses in internal medicine: a road-map for physicians.

Authors:  Marco Falcone; Ercole Concia; Ido Iori; Giuliana Lo Cascio; Antonino Mazzone; Federico Pea; Francesco Violi; Mario Venditti
Journal:  Intern Emerg Med       Date:  2014-05-29       Impact factor: 3.397

8.  Spiromastigoides asexualis: Phylogenetic Analysis and Evaluation as a Cause of False-Positive Blastomyces DNA Probe Test Results.

Authors:  Minh-Vu H Nguyen; Nathan P Wiederhold; Connie Cañete-Gibas; Carmita Sanders; George R Thompson
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

9.  Disseminated cryptococcosis manifested as a single tumor in an immunocompetent patient, similar to the cutaneous primary forms.

Authors:  Danielle Mechereffe do Amaral; Ritha de Cássia Capelato Rocha; Luiz Euribel Prestes Carneiro; Dewton Moraes Vasconcelos; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

Review 10.  Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.

Authors:  Florence Ader; Anne-Lise Bienvenu; Blandine Rammaert; Saad Nseir
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.